NASDAQ: ICUI

ICU Medical (ICUI) Stock Analysis & Forecast

Nov 13 close

$179.27+1.97 (+1.1%)

Gekko Brief

AI summaryNov 9 close

ICU Medical's stock rose this week after third-quarter results showed revenue increasing to $556 million, up 4% on an adjusted basis with 5% organic growth, driven by strength in Infusion Systems and Consumables. Adjusted earnings per share reached $2.44, up from $2.03 a year ago, and the company maintained its 2026 outlook, now expecting to land at the higher end of its previously issued adjusted EBITDA and EPS guidance ranges. Management also repaid $80 million in debt, bringing net leverage below 2 times, and is scheduled to present at the Jefferies Global Healthcare Conference in London on 18 November.

ICUI closed at $178.85, up 3.9%, sitting above both its 50-day average of $162.98 and 200-day average of $149.02, with the shorter average above the longer one. The GekkoIndex reads 46.2, placing the stock in the Neutral zone, down from a higher reading five days prior. Price sits 23.6% above Gekko Fair Value of $144.72, a gap that stands out against the otherwise constructive trend picture.

The next earnings date falls on 18 February 2027, well outside a typical 20-trading-day holding window, with the prior report having produced a 10.9% reaction and an average absolute reaction of 9.3% across the last eight quarters, all of which beat estimates. No insider, Congress or unusual options activity appears in their respective windows. Seasonally, the next 20 trading days have averaged a 1.7% gain over four years, rising in three of them, while three analyst firms currently carry buy ratings with a consensus target of $193.38.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

ICU Medical price vs fair value

$179.27$147.73Nov ’25May ’26Nov ’26
Close $179.27200-day averageGekko Fair Value $147.73

ICU Medical quick facts

Market cap
$4.48B
P/E ratio
74.2
Forward P/E
18.8
EPS, TTM
$2.39
Revenue, TTM
$2.18B
Profit margin
2.8%
Dividend yield
—
Beta
0.88
Volume
195,453 avg 277,403
1-year return
+28.8%
Typical daily move
±4.1%
Typical 20-day move
±6.9%
50-day average
$163.72
200-day average
$149.60
Next earnings
Feb 18 after close
Shares outstanding
25.01M
52-week range
$113.37$192.85

ICU Medical swing-trade checklist

ICU Medical scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

3 supportive1 mixed1 headwind

  • Trendsupportive

    Above 50 and 200-day

    Close $179.27 is above the 50-day ($163.72) and 200-day ($149.60) averages, and the 50-day is above the 200-day.

    See the chart
  • GekkoIndexmixed

    48, Neutral

    Reading 48 is in the Neutral zone.

    See the GekkoIndex
  • Fair valueheadwind

    21.3% above

    Price is 21.3% above Gekko Fair Value (more than 5% above).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 95 days

    Next report Feb 18, 2027, 95 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +2.1% on average

    From this point in the calendar, the next 20 trading days averaged +2.1% over 4 years, rising in 3 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

ICU Medical stock chart and price history

ICU Medical closed at $179.27 on Nov 13, 2026, +28.8% over the past year, inside a 52-week range of $113.37 to $192.85.

Close50-day average200-day averageVolume
ICU Medical share price, past year, with 50-day and 200-day moving averages and volume$120$140$160DecJan 2026FebMarAprMayJunJulAugSepOctNov179.27

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+7.2%
3 months
−1.8%
6 months
+51.0%
1 year
+28.8%
The full ICUI chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open ICUI in Gekko

Follow ICU Medical through every session

Put ICUI on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track ICUI in GekkoFree for 7 days. No credit card required.

About ICU Medical

ICU Medical designs, manufactures and sells medical devices used in infusion therapy and critical care, working through subsidiaries around the world. Its offerings span needlefree connectors, catheter maintenance and disinfection tools, hemodialysis accessories, and systems for safely handling hazardous drugs during compounding. The company is also known for its intravenous fluids and irrigation solutions, its infusion pumps such as Plum 360 and LifeCare PCA, and software that links smart pumps to hospital records, asset tracking and alarm systems.

Beyond infusion products, ICU Medical supplies equipment for critical care settings, including hemodynamic monitoring systems, cardiac output and oximetry catheters, blood pressure transducers, and closed blood sampling systems. Alongside its devices, it offers related professional services. Its customers include acute care hospitals, wholesalers, ambulatory clinics, and other alternate-site providers such as outpatient centers, home healthcare services and long-term care facilities.

The company was established in 1984 and is headquartered in San Clemente, California. Its shares are listed on the NASDAQ under the ticker ICUI.

Listed
NASDAQ
Sector
Health technology
Industry
Medical specialties
Website
icumed.com

ICU Medical GekkoIndex: the smart money zone

ICU Medical’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 48, in the Neutral zone, down 2.3 points over five sessions.

010048Neutral

Down 2.3 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying21+4.3%+5.6%+6.1%+6.1%
Accumulation170+1.0%+1.4%+1.8%+7.2%
Neutral (current zone)348+0.4%+1.1%+2.7%+6.4%
Distribution37−0.2%+0.2%+2.4%+1.1%
Selling1Too few readings yet

Average ICUI share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the ICUI price, zone by zone.Track ICUI in Gekko

Is ICU Medical stock overvalued? Gekko Fair Value

ICU Medical trades 21.3% above Gekko Fair Value of $147.73, so the shares are overvalued on Gekko’s estimate.

Gekko’s own estimate of what ICU Medical shares are worth, recalculated every trading day.

$147.73

Gekko Fair Value, Nov 14, 2026

21.3% Overvalued

At the end of Aug 2026 the price was 5.7% below the estimate.

Gekko Fair ValueShare price, month end
$148$179Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open ICUI in Gekko

ICU Medical insider and Congress trading

No open-market insider purchases were filed for ICU Medical, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for ICUI in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every ICUI insider filing, plotted on the chart in Gekko.Open ICUI in Gekko

Congress trades last 90 days

No trades in ICUI were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for ICUI, plotted on the chart in Gekko.Open ICUI in Gekko

Buybacks

ICU Medical has been buying back its own shares.

Bought back, quarter ended Jun 30, 2026
$38.78M
As a share of market cap
0.86%
Trailing four quarters
$86.35M

From company filings.

Hedge funds and billionaires quarter ended Mar 31

1of the funds Gekko tracks holds ICUI.

0added0opened1trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko

ICU Medical earnings: next date and track record

ICU Medical reports on Feb 18, 2027, after the close (95 days away), and beat the EPS estimate in 8 of its last 8 reports.

8 of 8reports beat the EPS estimate
±9.3%average move across the report
6 of 8reports followed by a gain

Share-price move across each report

+25.5%Nov ’24−5.1%Feb ’25+2.8%May ’25−11.1%Aug ’25+10.0%Nov ’25+3.6%Feb ’26+5.7%May ’26+10.9%Aug ’26

Last earnings call, Aug 6, 2026 AI summary

What they said
ICU Medical reported Q2 2026 revenue of $548 million, with 6% organic growth and 1% reported growth (impacted by Otsuka ICU Medical JV deconsolidation). Adjusted gross margins reached 41%, adjusted EBITDA was $110 million, and adjusted EPS was $2.37. The company repaid $50 million in debt and targets approximately 2x leverage by year-end. IV Systems grew 12% organically, Consumables grew 5% organically hitting a record, while Vital Care declined 4% organically.
Guidance
Management expects Consumables to achieve mid-single-digit growth for the remainder of 2026. IV Systems organic growth is expected to continue at or above 6% in Q3. Vital Care expected to show stability but finish slightly down for the full year due to weak Q1 results.
ReportedEPSSurpriseRevenueSurpriseMove
Aug 6, 2026$2.01
est $1.49
+34.9%$547.9M
est $533.4M
+2.7%+10.9%
May 7, 2026$1.97
est $1.75
+12.6%$525.8M
est $520.6M
+1.0%+5.7%
Feb 19, 2026$1.91
est $1.69
+13.0%$535.9M
est $530.6M
+1.0%+3.6%
Nov 6, 2025$2.03
est $1.43
+42.0%$537.0M
est $511.5M
+5.0%+10.0%
Aug 7, 2025$2.10
est $1.44
+45.8%$548.9M
est $511.5M
+7.3%−11.1%
May 8, 2025$1.72
est $1.28
+34.4%$604.7M
est $603.7M
+0.2%+2.8%
Feb 27, 2025$2.11
est $1.48
+42.4%$629.8M
est $599.1M
+5.1%−5.1%
Nov 12, 2024$1.59
est $1.25
+27.2%$589.1M
est $574.6M
+2.5%+25.5%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

ICU Medical stock forecast and analyst price targets

Analysts’ average 12-month price target for ICU Medical is $194.25, +8.4% from the last close, from 3 firms rating the stock in the last 90 days.

$194.25consensus 12-month target, +8.4% from the last close
Low $189High $200
Buy3
Hold0
Sell0

Each firm’s latest rating in the last 90 days: 3 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 6Piper SandlerBuy, reiterated$200+11.6%
Nov 6KeyBancBuy, maintained$189+5.4%
Nov 5BTIGBuy, reiterated$200+11.6%
Sep 23Piper SandlerBuy, reiterated$195+8.8%
Sep 18Piper SandlerBuy, maintained$195+8.8%
+2.7%average 20-day move after past Neutral readings
+2.1%average move over the next 20 trading days in the last 4 years
±4.1%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

ICU Medical seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, ICU Medical averaged +2.1% across the last 4 years, rising in 3 of them.

Next 20 trading days, by year

−7.8%2021+2.6%2022+5.3%2023+8.4%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days0.0%2 of 4
Next 10 trading days−1.4%1 of 4
Next 15 trading days−1.5%1 of 4
Next 20 trading days+2.1%3 of 4
Next 30 trading days+3.6%2 of 4

For scale, ICUI’s typical 20-trading-day move in either direction is about 6.9%.

ICU Medical market cap and key statistics

ICU Medical’s market cap is $4.48B, with a P/E ratio of 74.2 and revenue of $2.18B over the last twelve months.

Valuation

Market cap
$4.48B
P/E ratio
74.2
Forward P/E
18.8
EPS, TTM
$2.39
Gekko Fair Value
$147.73

Trading

Volume
195,453
Avg volume, 20 days
277,403
52-week high
$192.85
52-week low
$113.37
Shares outstanding
25.01M

Financials

Revenue, TTM
$2.18B
Profit margin
2.8%
Return on equity
2.8%
Quarterly earnings growth, YoY
−46.9%

Risk and income

Beta
0.88
Typical daily move
±4.1%
Typical 20-day move
±6.9%

ICU Medical peers

ICU Medical’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
TMOThermo Fisher Scientific−0.2%Neutral15.0% above
ABTAbbott Laboratories+0.3%Neutral10.5% below
DHRDanaher0.0%Neutral4.7% above
ISRGIntuitive Surgical0.0%Neutral17.5% above
MDTMedtronic+0.7%Neutral14.2% below
SYKStryker−2.0%Neutral0.1% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Medical specialties

ICU Medical stock FAQ

What is ICU Medical’s market cap?

ICU Medical’s market cap is $4.48B at the Nov 13, 2026 close of $179.27, with 25.01M shares outstanding. The shares trade on a P/E ratio of 74.2.

What is the ICU Medical stock forecast?

The consensus analyst 12-month price target for ICU Medical is $194.25, +8.4% from the last close. Of the 3 firms that rated the stock in the last 90 days, 3 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is ICU Medical stock overvalued or undervalued?

On Gekko’s estimate ICU Medical is overvalued: the Nov 13, 2026 close of $179.27 is 21.3% above Gekko Fair Value of $147.73. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does ICU Medical report earnings next?

ICU Medical is expected to report on Feb 18, 2027, after the market closes (95 days away). Analysts expect earnings of $2.15 per share on revenue of $559.3M. ICU Medical beat the earnings estimate in 8 of its last 8 reports, moving 9.3% on average across the report.

What is ICU Medical’s 52-week high and low?

ICU Medical’s 52-week high is $192.85 and its 52-week low is $113.37; it closed at $179.27 on Nov 13, 2026, +28.8% over the past year. Over the last five years the shares peaked at $251.77 on Nov 19, 2021.

Is ICU Medical stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, earnings risk and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See ICU Medical the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.